More Articles

International Psoriasis Council releases consensus statement on biosimilars Biosimilars/General | Posted 30/10/2020

The International Psoriasis Council (IPC) Biosimilar Working Group (BSWG) published their consensus statements for the use of biosimilars in the treatment of patients with psoriasis [1]. 

Canada approves trastuzumab biosimilar Kanjinti Biosimilars/News | Posted 30/10/2020

Canada’s medicines regulator, Health Canada, has approved the trastuzumab biosimilar Kanjinti by Amgen. This marks the second trastuzumab biosimilar to be approved by Health Canada.

Role of efficacy trials in biosimilar assessments questioned Biosimilars/Research | Posted 30/10/2020

In recent years, the role of the comparative efficacy trial in biosimilar assessments has been brought into question. This is explored in a recent article published by Bielsky and colleagues [1].

Challenges faced by biosimilar orphan drugs in European health systems Reports | Posted 30/10/2020

As treatments for rare diseases become a greater healthcare priority, the contribution of biosimilars as a means of reducing costs and increasing patient access will become more important for the l...

Perceptions of biosimilars and switching in Arab rheumatologists Biosimilars/Research | Posted 30/10/2020

The introduction of biosimilars into the rheumatology field could lead to dramatic cost savings as has been observed in certain European countries. Their implementation and acquisition, however, is...

AbbVie accused of anticompetitive tactics to stop Humira biosimilars Policies & Legislation | Posted 30/10/2020

Pharmaceutical manufacturer AbbVie faces another legal challenge related to anticompetitive tactics in the US. On 12 October 2020, the US Public Interest Research Group (US PIRG) filed an appeal ac...

Medicure and Reliance sign cardiovascular drug agreement Pharma News | Posted 30/10/2020

Medicure Inc announced on 5 October 2020 that it has entered a License, Manufacture and Supply Agreement with Reliance Life Sciences Private Limited (RLS) for a cardiovascular drug. Under this agre...

FDA approves Glenmark and Cipla generics Generics/News | Posted 30/10/2020

Glenmark Pharmaceuticals and Cipla Limited have announced that they have received US food and Drug Administration (FDA) approval to market their generic drug products in the US. Both companies have...